Unknown

Dataset Information

0

Method to generate highly stable D-amino acid analogs of bioactive helical peptides using a mirror image of the entire PDB.


ABSTRACT: Biologics are a rapidly growing class of therapeutics with many advantages over traditional small molecule drugs. A major obstacle to their development is that proteins and peptides are easily destroyed by proteases and, thus, typically have prohibitively short half-lives in human gut, plasma, and cells. One of the most effective ways to prevent degradation is to engineer analogs from dextrorotary (D)-amino acids, with up to 105-fold improvements in potency reported. We here propose a general peptide-engineering platform that overcomes limitations of previous methods. By creating a mirror image of every structure in the Protein Data Bank (PDB), we generate a database of ?2.8 million D-peptides. To obtain a D-analog of a given peptide, we search the (D)-PDB for similar configurations of its critical-"hotspot"-residues. As a proof of concept, we apply our method to two peptides that are Food and Drug Administration approved as therapeutics for diabetes and osteoporosis, respectively. We obtain D-analogs that activate the GLP1 and PTH1 receptors with the same efficacy as their natural counterparts and show greatly increased half-life.

SUBMITTER: Garton M 

PROVIDER: S-EPMC5816147 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Method to generate highly stable D-amino acid analogs of bioactive helical peptides using a mirror image of the entire PDB.

Garton Michael M   Nim Satra S   Stone Tracy A TA   Wang Kyle Ethan KE   Deber Charles M CM   Kim Philip M PM  

Proceedings of the National Academy of Sciences of the United States of America 20180129 7


Biologics are a rapidly growing class of therapeutics with many advantages over traditional small molecule drugs. A major obstacle to their development is that proteins and peptides are easily destroyed by proteases and, thus, typically have prohibitively short half-lives in human gut, plasma, and cells. One of the most effective ways to prevent degradation is to engineer analogs from dextrorotary (D)-amino acids, with up to 10<sup>5</sup>-fold improvements in potency reported. We here propose a  ...[more]

Similar Datasets

| S-EPMC4642847 | biostudies-literature
| S-EPMC4201793 | biostudies-other
2024-01-19 | PXD046228 | Pride
| S-EPMC7217020 | biostudies-literature
| S-EPMC5643884 | biostudies-literature
| S-EPMC8596876 | biostudies-literature
| S-EPMC4905334 | biostudies-other
| S-EPMC6437144 | biostudies-literature
| S-EPMC5492103 | biostudies-literature
| PRJEB25012 | ENA